Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...
Saved in:
Main Authors: | , , , , , |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2020
|
在線閱讀: | https://doi.org/10.3389/fcell.2020.596679 https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|